Metformin ameliorates diabetic nephropathy in a rat model of low-dose streptozotocin-induced diabetes

Kashihara, 2010, Oxidative stress in diabetic nephropathy, Curr Med Chem, 17, 4256, 10.2174/092986710793348581

Yokoyama, 2015, Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36), Diabetes Res Clin Pract, 109, 485, 10.1016/j.diabres.2015.06.005

Ritz, 2006, Diabetic nephropathy, Saudi J Kidney Dis Transpl, 17, 481

Zou, 2014, Protective effect of total flavonoids extracted from the leaves of Murraya paniculata (L.) Jack on diabetic nephropathy in rats, Food Chem Toxicol, 64, 231, 10.1016/j.fct.2013.11.043

Gohda, 2014, Combat diabetic nephropathy: From pathogenesis to treatment, J Diabetes Res, 2014, 207140, 10.1155/2014/207140

Pan, 2010, The oxidative stress status in diabetes mellitus and diabetic nephropathy, Acta Diabetol, 47, S71, 10.1007/s00592-009-0128-1

Swaminathan, 2008, Novel approaches targeted toward oxidative stress for the treatment of chronic kidney disease, Curr Opin Nephrol Hypertens, 17, 143, 10.1097/MNH.0b013e3282f4e539

Tabak, 2011, Oxidative lipid, protein and DNA damage as oxidative stress markers in vascular complications of diabetes mellitus, Clin Invest Med, 34, E163, 10.25011/cim.v34i3.15189

Ho, 2012, Sustained Wnt/β-catenin signaling rescues high glucose induction of transforming growth factor-β1-mediated renal fibrosis, Am J Med Sci, 344, 374, 10.1097/MAJ.0b013e31824369c5

Zorena, 2013, Serum concentrations of transforming growth factor-Beta 1 in predicting the occurrence of diabetic retinopathy in juvenile patients with type 1 diabetes mellitus, J Diabetes Res, 2013, 614908, 10.1155/2013/614908

Chen, 2000, CTGF expression is induced by TGF-beta in cardiac fibroblasts and cardiac myocytes: A potential role in heart fibrosis, J Mol Cell Cardiol, 32, 1805, 10.1006/jmcc.2000.1215

Li, 2010, Mangiferin prevents diabetic nephropathy progression in streptozotocin-induced diabetic rats, Phytother Res, 24, 893, 10.1002/ptr.3045

Nasri, 2014, Metformin: Current knowledge, J Res Med Sci, 19, 658

Kirpichnikov, 2002, Metformin: An update, Ann Intern Med, 137, 25, 10.7326/0003-4819-137-1-200207020-00009

Grossmann, 2015, Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary Tumorigenesis, Curr Pharmacol Rep, 1, 312, 10.1007/s40495-015-0032-z

Rafieian-Kopaei, 2013, Ginger and diabetic nephropathy, J Renal Inj Prev, 2, 9

Baradaran, 2012, Lipoprotein(a), type 2 diabetes and nephropathy; the mystery continues, J Nephropathol, 1, 126, 10.5812/nephropathol.8107

Kim, 2007, Effects of KIOM-79 on hyperglycemia and diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats, J Ethnopharmacol, 111, 240, 10.1016/j.jep.2006.11.023

Kong, 2013, Advances in murine models of diabetic nephropathy, J Diabetes Res, 2013, 797548, 10.1155/2013/797548

Dupuis, 2005, Captopril improves cerebrovascular structure and function in old hypertensive rats, Br J Pharmacol, 144, 349, 10.1038/sj.bjp.0706001

Szkudelski, 2001, The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas, Physiol Res, 50, 537

Lenzen, 2008, The mechanisms of alloxan- and streptozotocin-induced diabetes, Diabetologia, 51, 216, 10.1007/s00125-007-0886-7

Hall-Craggs, 1982, Acute renal failure and renal tubular squamous metaplasia following treatment with streptozotocin, Hum Pathol, 13, 597, 10.1016/S0046-8177(82)80280-3

Tay, 2005, Can murine diabetic nephropathy be separated from superimposed acute renal failure?, Kidney Int, 68, 391, 10.1111/j.1523-1755.2005.00405.x

Jiang, 2013, Early life factors and type 2 diabetes mellitus, J Diabetes Res, 2013, 485082, 10.1155/2013/485082

Lee, 2013, Disruption of the cereblon gene enhances hepatic AMPK activity and prevents high-fat diet-induced obesity and insulin resistance in mice, Diabetes, 62, 1855, 10.2337/db12-1030

Mogensen, 1983, The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy, Diabetes, 32, S64, 10.2337/diab.32.2.S64

Viberti, 2002, Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: A blood pressure-independent effect, Circulation, 106, 672, 10.1161/01.CIR.0000024416.33113.0A

Wang, 2004, A study comparing the prevalence of urinary albumin excretion and microalbuminuria in pre-diabetes subjects, Zhonghua Nei Ke Za Zhi, 43, 170

Stirban, 2013, Vascular effects of advanced glycation endproducts: Clinical effects and molecular mechanisms, Mol Metab, 3, 94, 10.1016/j.molmet.2013.11.006

Sakai, 1996, Localization of glycated proteins in the glomeruli of patients with diabetic nephropathy, Nephrol Dial Transplant, 11, S66, 10.1093/ndt/11.supp5.66

Rösen, 2001, The role of oxidative stress in the onset and progression of diabetes and its complications: A summary of a Congress Series sponsored by UNESCO-MCBN, the American diabetes association and the german diabetes society, Diabetes Metab Res Rev, 17, 189, 10.1002/dmrr.196

Iwasaki, 2010, Estimated glomerular filtration rate is superior to measured creatinine clearance for predicting postoperative renal dysfunction in patients undergoing pancreatoduodenectomy, Pancreas, 39, 20, 10.1097/MPA.0b013e3181bab521

Yan, 2009, Analysis of oxidative modification of proteins, Curr Protoc Protein Sci Chapter, 14, Unit14.4

Booth, 1997, In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs). Novel inhibition of post-Amadori glycation pathways, J Biol Chem, 272, 5430, 10.1074/jbc.272.9.5430

Miyoshi, 2002, Aminoguanidine pyridoxal adduct is superior to aminoguanidine for preventing diabetic nephropathy in mice, Horm Metab Res, 34, 371, 10.1055/s-2002-33478

Wagener, 2009, The role of reactive oxygen species in apoptosis of the diabetic kidney, Apoptosis, 14, 1451, 10.1007/s10495-009-0359-1

Singh, 2011, Oxidative stress in early diabetic nephropathy: Fueling the fire, Nat Rev Endocrinol, 7, 176, 10.1038/nrendo.2010.212

Krishan, 2011, Diabetic nephropathy: Aggressive involvement of oxidative stress, J Pharm Educ Res, 2, 35

Mima, 2013, Inflammation and oxidative stress in diabetic nephropathy: New insights on its inhibition as new therapeutic targets, J Diabetes Res, 2013, 248563, 10.1155/2013/248563

Shao, 2013, Relationship between oxidant/antioxidant markers and severity of microalbuminuria in the early stage of Nephropathy in type 2 diabetic Patients, J Diabetes Res, 2013, 232404, 10.1155/2013/232404

Grover, 2013, Molecular mechanisms involved in the bidirectional relationship between diabetes mellitus and periodontal disease, J Indian Soc Periodontol, 17, 292, 10.4103/0972-124X.115642

Iacopino, 2001, Periodontitis and diabetes interrelationships: Role of inflammation, Ann Periodontol, 6, 125, 10.1902/annals.2001.6.1.125

Howard, 1987, Lipoprotein metabolism in diabetes mellitus, J Lipid Res, 28, 613, 10.1016/S0022-2275(20)38659-4

Ma, 2014, Impaired β cell function in Chinese newly diagnosed type 2 diabetes mellitus with hyperlipidemia, J Diabetes Res, 2014, 493039, 10.1155/2014/493039

Moorhead, 1982, Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease, Lancet, 2, 1309, 10.1016/S0140-6736(82)91513-6

Krolewski, 1994, Hypercholesterolemia-a determinant of renal function loss and deaths in IDDM patients with nephropathy, Kidney Int Suppl, 45, S125

Ravid, 1995, Plasma lipids and the progression of nephropathy in diabetes mellitus type II: Effect of ACE inhibitors, Kidney Int, 47, 907, 10.1038/ki.1995.135

Rosario, 2006, Lipids and diabetic nephropathy, Curr Diab Rep, 6, 455, 10.1007/s11892-006-0079-7

Lee, 2003, Reactive oxygen species-regulated signaling pathways in diabetic nephropathy, J Am Soc Nephrol, 14, S241, 10.1097/01.ASN.0000077410.66390.0F

Choudhary, 2008, Interleukin-6 and C-reactive protein in pathogenesis of diabetic nephropathy: New evidence linking inflammation, glycemic control and microalbuminuria, Iran J Kidney Dis, 2, 72

Branchetti, 2013, Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm, Cardiovasc Res, 100, 316, 10.1093/cvr/cvt205

Vestra, 2005, Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes, J Am Soc Nephrol, 16, S78, 10.1681/ASN.2004110961

Sekizuka, 1994, Detection of serum IL-6 in patients with diabetic nephropathy, Nephron, 68, 284, 10.1159/000188281

Chen, 2013, Levels of inflammatory cytokines in type 2 diabetes patients with different urinary albumin excretion rates and their correlation with clinical variables, J Diabetes Res, 2013, 138969, 10.1155/2013/138969